These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 34042874)
21. Compatibility Between Metadata Standards: Import Pipeline of CDISC ODM to the Samply.MDR. Kock-Schoppenhauer AK; Ulrich H; Wagen-Zink S; Duhm-Harbeck P; Ingenerf J; Neuhaus P; Dugas M; Bruland P Stud Health Technol Inform; 2018; 247():221-225. PubMed ID: 29677955 [TBL] [Abstract][Full Text] [Related]
22. The Role of the European Reference Network for Rare Bone Diseases (ERN BOND) and European Registries for Rare Bone and Mineral Conditions (EuRR-Bone) in the Governance of the Management of Rare Bone and Mineral Diseases. Priego Zurita AL; Boarini M; Casareto L; Cherenko M; Mordenti M; Moroni A; Ahmed SF; Appelman-Dijkstra NM; Sangiorgi L Calcif Tissue Int; 2024 Nov; 115(5):498-506. PubMed ID: 39060404 [TBL] [Abstract][Full Text] [Related]
23. European expert network on rare communicable diseases and other rare diseases linked to mobility and globalisation focused on health care provision (EURaDMoG): a feasibility study. Requena-Méndez A; Bisoffi Z; Vives-Corrons JL; Gascon J; Plasència A Orphanet J Rare Dis; 2020 Oct; 15(1):291. PubMed ID: 33066818 [TBL] [Abstract][Full Text] [Related]
24. Implementation of EXABO - An Expert Advisory Board for the European Reference Network for Rare Respiratory Diseases. Walther D; Steinmann O; Wagner TOF; Storf H Stud Health Technol Inform; 2020 Jun; 270():986-990. PubMed ID: 32570529 [TBL] [Abstract][Full Text] [Related]
25. Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspective. Mañú Pereira MDM; Colombatti R; Alvarez F; Bartolucci P; Bento C; Brunetta AL; Cela E; Christou S; Collado A; de Montalembert M; Dedeken L; Fenaux P; Galacteros F; Glenthøj A; Gutiérrez Valle V; Kattamis A; Kunz J; Lobitz S; McMahon C; Pellegrini M; Reidel S; Russo G; Santos Freire M; van Beers E; Kountouris P; Gulbis B Lancet Haematol; 2023 Aug; 10(8):e687-e694. PubMed ID: 37451300 [TBL] [Abstract][Full Text] [Related]
26. ERN BOND: The key European network leveraging diagnosis, research, and treatment for rare bone conditions. Casareto L; Appelman-Dijkstra NM; Brandi ML; Chapurlat R; Cormier-Daire V; Hamdy NAT; Heath KE; Horn J; Mantovani G; Mohnike K; Sousa SB; Travessa A; Wekre LL; Zillikens MC; Sangiorgi L; Eur J Med Genet; 2024 Apr; 68():104916. PubMed ID: 38296035 [TBL] [Abstract][Full Text] [Related]
27. Towards FAIRification of sensitive and fragmented rare disease patient data: challenges and solutions in European reference network registries. Dos Santos Vieira B; Bernabé CH; Zhang S; Abaza H; Benis N; Cámara A; Cornet R; Le Cornec CMA; 't Hoen PAC; Schaefer F; van der Velde KJ; Swertz MA; Wilkinson MD; Jacobsen A; Roos M Orphanet J Rare Dis; 2022 Dec; 17(1):436. PubMed ID: 36517834 [TBL] [Abstract][Full Text] [Related]
28. Developing a standardized healthcare cost data warehouse. Visscher SL; Naessens JM; Yawn BP; Reinalda MS; Anderson SS; Borah BJ BMC Health Serv Res; 2017 Jun; 17(1):396. PubMed ID: 28606088 [TBL] [Abstract][Full Text] [Related]
29. Current state of rare disease registries and databases in Australia: a scoping review. Ruseckaite R; Mudunna C; Caruso M; Helwani F; Millis N; Lacaze P; Ahern S Orphanet J Rare Dis; 2023 Jul; 18(1):216. PubMed ID: 37501152 [TBL] [Abstract][Full Text] [Related]
30. [Creating a European registry of patient registries--a service oriented approach]. Pajić V; Pristas I; Meglic M Acta Med Croatica; 2013 Jun; 67(3):233-40. PubMed ID: 25007433 [TBL] [Abstract][Full Text] [Related]
31. Towards European harmonisation of healthcare for patients with rare immune disorders: outcome from the ERN RITA registries survey. Papa R; Cant A; Klein C; Little MA; Wulffraat NM; Gattorno M; Ruperto N; Orphanet J Rare Dis; 2020 Jan; 15(1):33. PubMed ID: 32000824 [TBL] [Abstract][Full Text] [Related]
32. A Medical Report Feature for OSSE Rare Disease Registries. Schueler K; Zieschank A; Göbel J; Vasseur J; Schaaf J; Hohenfellner K; Wildenhain S; Storf H Stud Health Technol Inform; 2021 May; 281():1085-1086. PubMed ID: 34042849 [TBL] [Abstract][Full Text] [Related]
33. Healthcare data warehouse system supporting cross-border interoperability. Gavrilov G; Vlahu-Gjorgievska E; Trajkovik V Health Informatics J; 2020 Jun; 26(2):1321-1332. PubMed ID: 31581924 [TBL] [Abstract][Full Text] [Related]
34. Telemedicine strategy of the European Reference Network ITHACA for the diagnosis and management of patients with rare developmental disorders. Smith M; Alexander E; Marcinkute R; Dan D; Rawson M; Banka S; Gavin J; Mina H; Hennessy C; Riccardi F; Radio FC; Havlovicova M; Cassina M; Emandi AC; Fradin M; Gompertz L; Nordgren A; Traberg R; Rossi M; Trimouille A; Sowmyalakshmi R; Dallapiccola B; Renieri A; Faivre L; Kerr B; Verloes A; Clayton-Smith J; Douzgou S; Orphanet J Rare Dis; 2020 Apr; 15(1):103. PubMed ID: 32334637 [TBL] [Abstract][Full Text] [Related]
35. How to design a registry for undiagnosed patients in the framework of rare disease diagnosis: suggestions on software, data set and coding system. Berger A; Rustemeier AK; Göbel J; Kadioglu D; Britz V; Schubert K; Mohnike K; Storf H; Wagner TOF Orphanet J Rare Dis; 2021 May; 16(1):198. PubMed ID: 33933089 [TBL] [Abstract][Full Text] [Related]
36. The value of a European registry for pituitary adenomas: the example of Cushing's syndrome registry. Webb SM; Santos A; Valassi E Ann Endocrinol (Paris); 2012 Apr; 73(2):83-9. PubMed ID: 22541996 [TBL] [Abstract][Full Text] [Related]
38. Rare Disease Biospecimens and Patient Registries: Interoperability for Research Promotion, a European Example: EuroBioBank and SpainRDR-BioNER. Rubinstein YR; Posada de la Paz M; Mora M Adv Exp Med Biol; 2017; 1031():141-147. PubMed ID: 29214569 [TBL] [Abstract][Full Text] [Related]
39. The European Union Policy in the Field of Rare Diseases. Moliner AM; Waligora J Adv Exp Med Biol; 2017; 1031():561-587. PubMed ID: 29214592 [TBL] [Abstract][Full Text] [Related]
40. The need for widely available genomic testing in rare eye diseases: an ERN-EYE position statement. Black GC; Sergouniotis P; Sodi A; Leroy BP; Van Cauwenbergh C; Liskova P; Grønskov K; Klett A; Kohl S; Taurina G; Sukys M; Haer-Wigman L; Nowomiejska K; Marques JP; Leroux D; Cremers FPM; De Baere E; Dollfus H; Orphanet J Rare Dis; 2021 Mar; 16(1):142. PubMed ID: 33743793 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]